Medifast Inc Stock Performance
| MED Stock | USD 14.14 0.41 2.82% |
The company secures a Beta (Market Risk) of 0.15, which conveys not very significant fluctuations relative to the market. As returns on the market increase, MEDIFAST INC's returns are expected to increase less than the market. However, during the bear market, the loss of holding MEDIFAST INC is expected to be smaller as well. At this point, MEDIFAST INC has a negative expected return of -0.28%. Please make sure to verify MEDIFAST INC's skewness, day typical price, and the relationship between the maximum drawdown and daily balance of power , to decide if MEDIFAST INC performance from the past will be repeated in the future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days MEDIFAST INC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more
Actual Historical Performance (%)
One Day Return (2.82) | Five Day Return 1.22 | Year To Date Return (18.22) | Ten Year Return (53.56) | All Time Return 157.09 |
Dividend Date 2023-11-07 | Ex Dividend Date 2023-09-18 |
1 | Acquisition by Jeffrey Brown of 3289 shares of MEDIFAST INC subject to Rule 16b-3 | 12/20/2024 |
2 | Disposition of tradable shares by Jonathan Mackenzie of MEDIFAST INC at 18.9 subject to Rule 16b-3 | 01/17/2025 |
3 | Medifast to Release Quarterly Earnings on Tuesday - MarketBeat | 02/13/2025 |
4 | Adia Med Partners with Premier FDA-Approved Lab for High-Quality Umbilical Cord Stem Cell and Exosome Products | 02/18/2025 |
5 | Q4 2024 Medifast Inc Earnings Call Transcript | 02/19/2025 |
6 | Institutional owners may take dramatic actions as Medifast, Inc.s recent 11 percent drop adds to one-year losses | 02/21/2025 |
7 | Acquisition by Daniel Chard of 34076 shares of MEDIFAST INC subject to Rule 16b-3 | 03/07/2025 |
8 | Acquisition by Jeffrey Brown of tradable shares of MEDIFAST INC at 68.89 subject to Rule 16b-3 | 03/14/2025 |
| Begin Period Cash Flow | 94.4 M |
MEDIFAST |
MEDIFAST INC Relative Risk vs. Return Landscape
If you would invest 1,714 in MEDIFAST INC on December 19, 2024 and sell it today you would lose (300.00) from holding MEDIFAST INC or give up 17.5% of portfolio value over 90 days. MEDIFAST INC is generating negative expected returns assuming volatility of 2.7522% on return distribution over 90 days investment horizon. In other words, 24% of stocks are less volatile than MEDIFAST, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
MEDIFAST INC Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for MEDIFAST INC's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as MEDIFAST INC, and traders can use it to determine the average amount a MEDIFAST INC's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1025
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MED |
Estimated Market Risk
| 2.75 actual daily | 24 76% of assets are more volatile |
Expected Return
| -0.28 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.1 actual daily | 0 Most of other assets perform better |
Based on monthly moving average MEDIFAST INC is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of MEDIFAST INC by adding MEDIFAST INC to a well-diversified portfolio.
MEDIFAST INC Fundamentals Growth
MEDIFAST Stock prices reflect investors' perceptions of the future prospects and financial health of MEDIFAST INC, and MEDIFAST INC fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on MEDIFAST Stock performance.
| Return On Equity | 0.0102 | ||||
| Return On Asset | 0.0324 | ||||
| Profit Margin | 0 % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 10.74 M | ||||
| Shares Outstanding | 10.94 M | ||||
| Price To Earning | 13.99 X | ||||
| Price To Book | 0.75 X | ||||
| Price To Sales | 0.26 X | ||||
| Revenue | 602.46 M | ||||
| Gross Profit | 444.62 M | ||||
| EBITDA | 2.88 M | ||||
| Net Income | 2.09 M | ||||
| Cash And Equivalents | 87.69 M | ||||
| Cash Per Share | 5.57 X | ||||
| Total Debt | 16.12 M | ||||
| Debt To Equity | 0.43 % | ||||
| Current Ratio | 1.29 X | ||||
| Book Value Per Share | 19.71 X | ||||
| Cash Flow From Operations | 24.48 M | ||||
| Earnings Per Share | 0.19 X | ||||
| Market Capitalization | 159.14 M | ||||
| Total Asset | 284.21 M | ||||
| Retained Earnings | 176.78 M | ||||
| Working Capital | 150.24 M | ||||
| Current Asset | 88.07 M | ||||
| Current Liabilities | 23.56 M | ||||
About MEDIFAST INC Performance
By analyzing MEDIFAST INC's fundamental ratios, stakeholders can gain valuable insights into MEDIFAST INC's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if MEDIFAST INC has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if MEDIFAST INC has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 98.10 | 93.19 | |
| Return On Tangible Assets | 0.01 | 0.01 | |
| Return On Capital Employed | 0.01 | 0.01 | |
| Return On Assets | 0.01 | 0.01 | |
| Return On Equity | 0.01 | 0.01 |
Things to note about MEDIFAST INC performance evaluation
Checking the ongoing alerts about MEDIFAST INC for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for MEDIFAST INC help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| MEDIFAST INC generated a negative expected return over the last 90 days | |
| MEDIFAST INC has a poor financial position based on the latest SEC disclosures | |
| Over 83.0% of the company shares are owned by institutional investors | |
| Latest headline from MacroaxisInsider: Acquisition by Daniel Chard of 34076 shares of MEDIFAST INC subject to Rule 16b-3 |
- Analyzing MEDIFAST INC's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether MEDIFAST INC's stock is overvalued or undervalued compared to its peers.
- Examining MEDIFAST INC's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating MEDIFAST INC's management team can have a significant impact on its success or failure. Reviewing the track record and experience of MEDIFAST INC's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of MEDIFAST INC's stock. These opinions can provide insight into MEDIFAST INC's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for MEDIFAST Stock analysis
When running MEDIFAST INC's price analysis, check to measure MEDIFAST INC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEDIFAST INC is operating at the current time. Most of MEDIFAST INC's value examination focuses on studying past and present price action to predict the probability of MEDIFAST INC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEDIFAST INC's price. Additionally, you may evaluate how the addition of MEDIFAST INC to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |